How AI-Powered Phenotyping Enhances the Patient Journey for Life Science Applications
In this episode of tHEORetically Speaking, Dr. Joseph Zabinksi, VP and Head of Commercial Strategy and AI at OM1, explains how AI-powered digital phenotyping can enhance our understanding of patients' experiences and inform access, treatment, and condition management.
Bridging Urban-Rural Healthcare Gaps Through Real-World Data
Medical research and clinical trials have historically favored urban communities, resulting in an underrepresentation of rural [...]
Urgent Transparency Needed in H5N1 Bird Flu Outbreaks Affecting U.S. Dairy Cattle
As H5N1 bird flu spreads across U.S. dairy cattle herds, significant concerns have arisen regarding the [...]
Debate Over U.S. Maternal Mortality Rates: Real Crisis or Data Misinterpretation?
A contentious debate has emerged among maternal health experts regarding the actual state of U.S. maternal [...]
The Stigma and Systemic Barriers Against Lifesaving Opioid Addiction Treatments in the U.S.
The opioid overdose epidemic has been devastating the U.S. for nearly three decades despite the availability [...]
Major US Pharmacy Chains to Offer Abortion Pill Mifepristone
CVS and Walgreens, the two largest pharmacy chains in the United States, announced plans to dispense [...]
Global Cholera Vaccine Shortage: A Crisis Amplified
The world faces an unprecedented cholera vaccine shortage amidst surging outbreaks across developing nations in Asia, [...]
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
In this webinar, panelists address integrating patient-centered research into real-world studies, focusing on diversity, equity, and inclusion (DEI), and developing systemic approaches for a more equitable research ecosystem.
Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults
Watch this webinar on addressing early onset cancer through strategic trial design, targeted launch indications, and increased trial access to speed up the delivery of impactful treatments.
Implementing Diversity Action Plans in Clinical Trials: Navigating FDA Requirements and Enhancing Inclusivity
In April 2022, the FDA mandated that all Phase 3 and pivotal studies include a Diversity [...]
Pioneering the Path for FDA Approval of Gender-Affirming Hormone Therapies: The Research Institute for Gender Therapeutics’ Groundbreaking Initiative
The Research Institute for Gender Therapeutics (RIGT), a nonprofit organization, is pioneering research to gain FDA [...]
Medicaid Disenrollment: Procedural Issues Leave 10 Million People Without Coverage, Children Majorly Affected
Over the past six months, 10 million people have been disenrolled from Medicaid, according to a [...]
The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
Abortion Bans and Mental Health Exceptions: Implications for Women’s Reproductive Care
Key Points: More than a dozen U.S. states have implemented near-total abortion bans following the overturning [...]
Tentative Four-Year Contract Agreement Reached Between Kaiser Permanente and Unions Following Historic Strike
After a historic strike, Kaiser Permanente and the Coalition of Kaiser Permanente Unions have reached a [...]
Optimizing Clinical Trials for Greater Payer Acceptance and Enhanced Patient Access
Biopharma manufacturers face challenges in conveying the clinical value of their medicines to payers due to [...]
Is AI the Future of Pharma?
Here's What People Are Saying... ChatGPT is revolutionizing the pharmaceutical industry. Artificial intelligence and machine learning are expediting medication development, [...]
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.
COVID-19 and Racial/Ethnic Disparities in Health
The COVID-19 pandemic has been characterized by surges in infections in different parts of the country at different times. The most recent rebound of COVID cases, however, indicates that the COVID-19 pandemic is not just a series of isolated surges that is “one and done.”
Sex Reassignment Surgery For Transgenders: Should It Be Covered By Health Insurance?
People who identify themselves as transgender evolved in their belief of a gender-assignment mistake when they are self-aware of stereotypes [...]
Real-World Evidence: Why Patients Matter.
"Take 2 tablets and call me in the morning" We've moved, finally, beyond assuming that an off-the-cuff statement like “take [...]
